Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wharton's Jelly Allograft for Lumbar Pain
NCT06361485Phase 1Recruiting
- Sponsor
- R3 Stem Cell
- Start
- Mar 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in low back pain (LBP), sponsored by R3 Stem Cell. Primary endpoints: C-reactive protein at 1 year, Erythrocyte sedimentation rate at 1 year and 6 more. Started Mar 2024; status: recruiting.
02
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT06361485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06361485.